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ABSTRACT 
Backgrounds. Colorectal cancer (CRC) incidence has a tendency to 
increase in recent decades in many countries of the world. The present research 
explores the data on indications for organ-preserving operations in the CRC and 
analyzes new criteria for their implementation. Materials and research methods. 
A retrospective analysis of the clinical data of 120 patients with colorectal cancer 
(CRC) with a T3-4N0-1M0 stage of the disease was carried out, who were 
observed in the Oncoproctology Department of RSSPMCO and the Ministry of 
Health Care of Republic of Uzbekistan in the period from 2005 to 2015. Patients 
were divided into the main and control clinical groups. The main group included 
60 patients with RC who underwent various types of operations during complex 
treatment: abdominal-anal resection of the rectum (AARR), anterior resection of 
the rectum (ARR), Hartmann's operation. The control group included 60 patients 
with RC who underwent abdominal-perineal extirpation of the rectum (APER). 
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Results and discussion. The results of organ-preserving operations in the complex 
treatment of CRC were observed during three and five years. Cases of relapses and 
metastases were analyzed, and the survival of patients over a three- and five-year 
period was evaluated, depending on prognostic factors. During the three-year 
observation, local relapses in the main group occurred in 10 (16.6%) patients with 
RC and in the control group in 13 (21.7%) patients. The average relapse rate was 
11,82,4 months. Conclusion. A new method has been developed for the complex 
treatment of patients with CRC, including preoperative high-dose 
hypoxiradiotherapy, followed by organ-conserving operations. Besides a new 
approach has been developed for the complex treatment of patients with CRC, 
including preoperative endolymphatic polychemotherapy and regional lymphatic 
polychemotherapy, as well as in combination with hypoxiradiotherapy.  
Key words:  colorectal cancer, radiation therapy, ampullar colorectal cancer, 
perineal extirpation of the rectum. 
 
Introduction. 
The main and most effective method in the treatment of CRC is the surgical 
method, in compliance with the principles of oncological radicalism. However, the 
use of only the surgical method of treating CRC demonstrates low efficiency - over 
the past 20-25 years, 5-year survival rates, which average 52%, have remained 
stably low. In this case, the cause of death of approximately 68% of patients is 
relapse of cancer after surgery, and the incidence of locoregional metastases ranges 
from 20-40% [3]. These failures determine the feasibility of finding ways to 
increase an acceptable and effective method of treatment through the use of 
combined and complex treatment methods for CRC. 
Recent decades have been characterized by the search for optimal regimens 
for combined and complex treatment of CRC by combining the surgical method 
with radiatiotherapy or chemotherapy in order to improve the treatment outcomes 
of a severe category of patients with a locally advanced process and the presence 
of metastases [4]. 
In modern clinical oncology, the search for the most effective methods for 
combining surgical intervention with various options for radiation therapy 
(preoperative, intra- or postoperative), as well as large-fraction ones [5]. At the 
same time, to date, there are no clear indications on the timing, doses and methods 
of exposure to radiation therapy in PKK, which indicates the need to find ways to 
improve and increase the effectiveness of this method of exposure [6]. 
The practical significance of the research results. Developed indications 
for organ-preserving surgical interventions for lower ampullar colorectal cancer, 
the most effective variants of chemoradiation methods have been proposed in the 
practical health care system of Uzbekistan. 
The developed variants of the schemes and methods of combined and 
complex therapy, improvement of the surgical technique, methods of correction 
and prevention of complications help to reduce the incidence of early postoperative 
complications, mortality rate, as well as the occurrence of relapses and metastases, 
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which will increase the effectiveness of treatment, improve the quality of life of 
patients and reduce terms of their rehabilitation. 
Based on the studies, the basic scientific provisions that are made are 
substantiated and formulated: 
1. An analysis of the dependence of the number of postoperative 
complications in patients with colorectal cancer associated with performing 
surgical intervention showed that after organ-sparing surgeries, complications were 
observed in 14 (11.2%) patients, and after performing peritoneal perineal 
extirpation of the rectum (PPER) - in 14 (9.5%) patients. Analysis of postoperative 
complications of a general nature showed that their number did not depend on the 
type of surgical intervention. 
2. On the example of 120 patients with rectal cancer with T3-4N0-1M0 
stages of the disease, the possibility of performing organ-saving operations in this 
category of patients is shown. The presence of severe concomitant pathology along 
with the individual characteristics of tumor growth may serve as a contraindication 
to performing such operations. 
3. New methods have been developed for the complex treatment of patients 
with colorectal cancer, including various schemes of preoperative high-dose 
radiation therapy, as well as methods of preoperative lymphatic polychemotherapy 
with subsequent organ-preserving operations. 
4. The five-year survival rate for patients with colorectal cancer after 
complex treatment with organ-preserving surgeries was 75.2%, and in patients in 
the control group after complex treatment with PPER , 74.8%. Moreover, in the 
group of patients with organ-sparing surgeries after carrying out the methods of 
lymphatic polychemotherapy, this indicator amounted to 76.1%, and after various 
schemes of high-dose radiation therapy - 73.0%. 
5. Organ-saving operations in the complex treatment of patients with rectal 
cancer with T3-4N0-1M0 stages of the disease significantly increase the quality of 
life of this category of patients, their social and labor rehabilitation, without 
compromising overall and relapse-free survival rates, which makes it possible to 
recommend the use of these techniques in complex treatment of this category of 
patients. 
Diagnosis and treatment of locally advanced colorectal cancer. The five-
year observation of patients with CRC in the T1N0M0 stage after surgical 
treatment is 90%; T2N0M0 after combined treatment - 70-80%; T3N0M0 after 
combined treatment - 60-65%, and after only surgical treatment 50-55%. T1-3N1-
3M0 after combined treatment is 50-55%, and after only surgical treatment - 25-
30%. In the T4N0-1M0 stage, 10-15% [8]. 
The situation when the neoplasm has exceeded not only the intestinal wall, 
but also the periintestinal tissue and has spread to nearby organs, or to the pelvic 
peritoneum, perivesical tissue, etc. commonly called locally distributed RC. [9] 
More broadly, the concept of locally distributed RC may include the following 
definition: an immobile or limitedly mobile tumor, circularly covering all the walls 
of the intestine, 5 cm long, narrowing the lumen of the intestine with the 
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involvement of neighboring organs and tissues and possible formation of fistulas 
or purulent cavities, and not having distant metastases [10]. 
The most adverse forms are mucous adenocarcinoma, cricoid-cell, 
undifferentiated cancer, and unclassified tumors. With a relatively small damage to 
the intestinal mucosa, they metastasize faster and more often spread not only to the 
entire intestinal wall, but also to surrounding tissues and organs. PKK can 
germinate in any adjacent organs or tissues. The bladder, small intestine, pelvic 
bones, ovaries, uterus, posterior wall of the vagina, prostate and seminal vesicles 
are most commonly affected. However, such germination is not always 
accompanied by distant metastasis, therefore, in such cases, it is advisable to 
conduct combined resections. 
Local tumor growth and lymphogenous metastasis in RC are interrelated, but 
not always parallel. So, 15% of tumors limited by the muscle layer of the intestinal 
wall are accompanied by lymphogenous metastasis. When germinating in all layers 
of the intestinal wall, the lymph nodes are affected in more than 50% of cases. At 
the same time, even when the tumor invades the neighboring organs (locally 
advanced forms of cancer), lymphogenous metastasis is often (30%) absent. 
According to many authors, 70-80% of patients with RC enter clinics with 
stage III-IV disease. Among the reasons for the late diagnosis of RC, it should be 
noted the absence of a mandatory standard examination scheme for a patient who 
suspects this disease, the inadequate use of previously developed diagnostic 
methods, and the limited use of new examination methods [11]. 
The primary RC is characterized by the fact that the tumor remains localized 
for a long time and grows relatively slowly compared to other tumors of the 
digestive tract. Localized and slow growth is also characteristic of metastases to 
the lymph nodes. Given this biological feature of RC, it was suggested that by 
increasing the number of lymphadenectomy, a reduction in the number of relapses 
can be achieved. At the same time, according to many researchers, the average 
five-year survival of patients, even when the operation is expanded to total 
pelvioabdominal lymphadenectomy, ranges from 45 to 60%. [12] 
In this regard, increasing the effectiveness of treatment for RC, today remains 
an urgent problem of modern oncology. In recent decades, there has been a 
tendency to expand indications for organ-preserving operations in the RC. Many 
authors note that even with a pronounced spread of the cancer process, distant 
metastases may be absent, and it is possible to perform extended surgical 
interventions. [13] At the same time, it is necessary to formulate clear criteria for 
their implementation on the basis of a comparative analysis of the long-term results 
of treatment, the frequency of local regional relapses; the introduction of combined 
and comprehensive treatment programs that increase the flexibility of surgical 
interventions. [14] 
Modern directions of organ-preserving surgical treatment of colorectal 
cancer. Modern methods of surgery for colorectal cancer are numerous. To choose 
one of them  is directly dependent on the location of the tumor, its type of growth, 
degree of spread, its anatomical features, the patient’s condition and the surgeon’s 
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qualifications. When choosing surgical tactics in patients with colorectal cancer 
with sprouting into neighboring organs, one should be guided not only by such 
criteria as the size of the tumor, its location, growth form and histological 
structure, which always determine the technical capabilities of radical surgery, but 
such the most important prognostic factor, as the depth of tumor invasion. [15] An 
operation can be considered radical only if, along with a sufficiently wide resection 
of the area of the intestine affected by the tumor, the zone of possible regional 
metastasis is also removed. 
The main and most effective method of treating RC is the surgical method, 
in compliance with the principles of oncological radicalism. However, the use of 
only the surgical method of treating RC demonstrates low efficiency - for 20–25 
years, 5-year survival rates after radical surgeries remain at 46–62%, which is an 
average of 52%. Many authors attribute the main causes of failures in the surgical 
method of treatment to the occurrence of relapses and distant metastases that occur 
at different times after surgery. The cause of death in approximately 68% of 
patients is cancer recurrence after surgery, and the incidence of locoregional 
metastases ranges from 20-40%. [16] These failures determine the feasibility of 
finding ways to increase an acceptable and effective method of treatment through 
the use of combined and complex treatment methods for RC. 
Among the many factors that determine the nature and extent of surgical 
interventions, and first of all organ-preserving ones, the fundamental role belongs 
to the degree of local spread of the tumor process and the level of tumor 
localization in the rectum. In RPK, typical operations depending on the height of 
the primary tumor are: anterior resection, abdominal-anal resection of the rectum 
with sigmoid reduction, obstructive resection (Hartmann's surgery) and abdominal-
perineal extirpation (BPE) of the rectum [17] 
Common forms of RC are often the main reason for abandoning active 
surgical tactics. Often, patients in this group perform symptomatic palliative 
surgery, in which there are a large number of postoperative complications and high 
rates of postoperative mortality. At the same time, the quality of life of these 
patients is significantly deteriorating, which is due to the increasing effect on their 
body of the not removed primary tumor and the progression of metastatic growth. 
The average life expectancy of these patients does not exceed 3–7 months. [18] 
The main argument of opponents of superradical interventions is the high 
technical complexity and invasiveness of the latter. However, many surgeons do 
not agree with this judgment, since long-term world practice of performing 
combined and advanced operations not only allows us to hope for good long-term 
results, but also opens up great prospects for improving the quality of life of 
patients by performing simultaneous or delayed plastic surgeries. [19] 
The current trend in locally advanced RC can be attributed to the tendency to 
perform saving interventions in the form of trans-abdominal resection and 
abdominal-anal resection of the rectum, naturally, in the absence of oncological 
contraindications. The postoperative mortality in these interventions is not much 
higher than that in conventional operations - for example, 30-40% of patients 
5
Yusupbekov et al.: OPPORTUNITIES FOR ORGAN-SAVING SURGERIES IN THE COMPLEX TREATMENT
Published by 2030 Uzbekistan Research Online, 2019
Central Asian Journal of Medicine 
uzjournals.edu.uz/tma 177 2020#1 
undergoing combined operations survive a 5-year period. One of the important 
contraindications for performing combined operations is the presence of 
concomitant diseases that cannot be corrected in the preoperative period, especially 
in elderly patients. [20] 
Materials and research methods. A retrospective analysis of the clinical 
data of 120 patients with colorectal cancer (CRC) with a T3-4N0-1M0 stage of the 
disease was carried out, who were treated in the Oncoproctology Department of 
RSSPMCO and the Ministry of Health Care of Republic of Uzbekistan in the 
period from 2005 to 2015. 
Patients were divided into the main and control clinical groups. The main 
group included 60 patients with RC who underwent various types of operations 
during complex treatment: abdominal-anal resection of the rectum (AARR), 
anterior resection of the rectum (ARR), Hartmann's operation. The control group 
included 60 patients with RC who underwent abdominal-perineal extirpation of the 
rectum (APER). 
In this case, the main and control groups of patients with RC were 
additionally divided into 3 subgroups depending on the nature of chemo- and 
radiatiotherapy (Tables 1, 2). Thus, patients in 1 subgroups received surgical 
treatment with endolymphatic polychemotherapy (ELPCH) and regional lymphatic 
polychemotherapy (RLPCH) and hypoxiradiotherapy (HRT), in 2 subgroups 
received surgical treatment in combination with radiatiotherapy (RT), in 3 
subgroups received surgical treatment in combined with ELPCH and RLPCH. 
We did not include in the observation of patients with acute intestinal obstruction, 
requiring emergency surgery, with a generalization of the process in the abdominal 
organs, ascites, lymphostasis, the presence of distant metastases, as well as with 
severe concomitant diseases requiring specialized treatment. 
Table 1 
Distribution of patients with colorectal cancer depending on the type of 
treatment in the main group, n = 60 
Sub- 
Group 
Type of 
operation 
Combination 
therapy 
 Number of patients 
Аbs. % 
 
1 
PRR, 
Hartmann's 
operation 
 
ELPCHT 
 
 
21 
 
35,0 
 
2  
PARR 
ELPCHT 23 
 
38,3 
3 LT 16 
 
26,7 
Total: 60 100 
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Table 2 
Distribution of patients with colorectal cancer depending on the type of 
treatment in the control group, n = 60 
Subgroup Type of 
operation 
Combination 
therapy 
Number of patients 
Аbs. % 
1  
PPER 
 
ELPCHT+RLPCHT 
+HRT 
19 
 
31,7 
2 ELPCHT+RLPCHT 24 
 
40,0 
3 LT 17 
 
28,3 
Total: 60 100 
 
A study of the distribution of patients by gender and age showed that in the 
main group of patients with RC there were 34 men (56.7%) and 26 women 
(43.3%), in the control group these figures were 36 (60%) and 24 (40 %) 
respectively. The average age of patients in the main group was 49.1 ± 0.8 years, in 
the control group - 48.9 ± 0.7 years. 
Table 3 
Distribution of patients with colorectal cancer by gender and age in the main 
group, n = 60 
Age Gender Total 
Men Women 
Аbs. % Аbs. % Аbs. % 
18-45 11 18,4 11 18,3 22 36,7 
46-60 14 23,3 7 11,7 21 35,0 
61 and upper 9 15,0 8 13,3 17 28,3 
Total: 34 56,7 26 43,3 60 100 
 
Table 4 
Distribution of patients with colorectal cancer by gender and age in the 
control group, n = 60 
Age Gender Total 
Мen Women 
Аbs. % Аbs. % Аbs. % 
18-45 18 30,0 9 15,0 27 45,0 
46-60 11 18,3 8 13,3 19 31,6 
60 and upper 7 11,7 7 11,7 14 23,4 
Total:  36 60 24 40 60 100 
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A study of the anamnesis of patients with PKK showed that in 17 (14.2%) of 
them, the duration of the disease was up to 3 months, in 42 (35%) - up to 6 
months, in 36 (30%) - up to 1 year, in 13 ( 10.8%) - up to 2 years and 12 
(10.0%) - up to 3 years (Table 5). 
Table 5 
Description of anamnesis of patients with colorectal cancer, n = 120 
Anamnesis of disease 
 Patients groups  Total 
Main Control 
Abs. % Аbs. % Аbs. % 
Up to 3 months 3 5,0 6 10,0 17 14,2 
Up to 6 months 14 23,3 12 20,0 42 35,0 
Up to 1 year 19 31,7 26 43,3 36 30,0 
Up to 2 year 17 28,3 14 23,4 13 10,8 
Up to 3 year 7 11,7 2 3,3 12 10,0 
Total 60 100 60 100 120 100 
 
This subjective indicator shows the presence of an erased RC clinic, as 
evidenced by a three- and six-month history in less than half of patients (44.1%). 
When conducting a rectoscopic examination, the exact localization of the 
tumor process and its extent was established (Table 6). As follows from the table, 
in the patients examined by us, the distal location of the tumor was mainly 
determined. So, during proctoscopy in 58 (48.3%) patients with CRC, the tumor 
was limited to localization in the anal canal. In rectoscopy in 50 (41.7%) patients, 
the tumor process was determined at a distance of 5–9 cm from the anus and in 12 
(10%) patients at a distance of 10 cm or more from the anus level. 
Table 6 
Localization of the tumor process in relation to its location from the 
anus, n = 120 
Tumor localization 
Patients groups Total 
Main Control 
Аbs. % Аbs. % Аbs. % 
In the anal canal 
(up to 3-4 cm) 
28 46,7 30 50,0 58 48,3 
At a distance of 5-9 cm 
from the anus 
26 43,3 24 40,0 50 41,7 
At a distance of 10cm 
from the anus 
6 10,0 6 10,0 12 10,0 
Total: 60 100 60 100 120 100 
 
In evaluating of disease prevalence, the TNM system was used (8th edition, 2008) 
(Table 7). As it follows from the table, stage IIa of the disease occurred in 18 
(30.9%) patients, IIb in 32 (19.1%) and stage IIIb in 70 (50.0%) patients. 
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Moreover, in 32 (26.7%) patients there was a local spread of the tumor process 
(T4N0-1M0). 
Table 7 
Distribution of patients with colorectal cancer according to the stages of the 
disease and the TNM system, n = 120 
 
Stage TNM 
Patients groups Total 
Main Control 
Аbs. % Аbs. % Аbs. % 
IIa T3N0M0 10 16,7 8 13,3 18 15,0 
IIb T4N0M0 16 26,7 16 26,7 32 26,7 
IIIb T3N1M0 18 30,0 20 33,3 38 31,7 
T4N1M0 16 26,6 16 26,7 32 26,6 
Total: 60 100 60 100 120 100 
 
The study of the histological structure of tumors showed that 
adenocarcinoma was predominantly found in 106 (88.3%) patients. At the same 
time, moderately differentiated adenocarcinoma was found in 39 (32.5%) patients, 
low-differentiated adenocarcinoma in 31 (25.8%) and highly differentiated 
adenocarcinomas in 36 (30.0%) patients with RC. Cricoid cell adenocarcinoma 
was diagnosed in 5 (4.2%) patients. Other histological forms of tumors were found 
in 9 (7.5%) patients. 
Table 8 
Distribution of patients with colorectal cancer depending on the 
histological structure of the tumor, n = 120 
    Histological form Patients groups Total 
Main Control 
Аbs. % Аbs. % Аbs. % Аbs. % 
Adeno 
carcinoma 
Highly 
differentiated 
 
14 
 
23,3 
 
22 
 
36,7 
 
36 
 
30,0 
 
 
 
 
106 
 
 
 
 
88,3 
Moderately 
differentiated 
 
25 
 
41,7 
 
14 
 
23,3 
 
39 
 
32,5 
Low  
differentiated 
 
15 
 
25,0 
 
16 
 
26,7 
 
31 
 
25,8 
 
Cricoid cell  
1 
 
1,7 
 
4 
 
6,7 
 
5 
 
4,2 
Other 
forms 
Slimy cancer 1 1,7 2 3,3 3 2,5  
 
14 
 
 
11,7 
Squamous cell 
carcinoma 
 
1 
 
1,6 
 
1 
 
1,7 
 
2 
 
1,7 
Undifferentiated 
cancer 
 
3 
 
5,0 
 
1 
 
1,6 
 
4 
 
3,3 
Total: 60 100 60 100 120 100 120 100 
 
9
Yusupbekov et al.: OPPORTUNITIES FOR ORGAN-SAVING SURGERIES IN THE COMPLEX TREATMENT
Published by 2030 Uzbekistan Research Online, 2019
Central Asian Journal of Medicine 
uzjournals.edu.uz/tma 181 2020#1 
Endolymphatic and regional lymphatic application of chemotherapy 
drugs. Preoperative endolymphatic polychemotherapy (ELPCH) and regional 
lymphatic chemotherapy (RLPCH) were performed in 47 (39.2%) patients with 
CRC, of which 23 (19.2%) were patients in the main group and 24 (20.07%) were 
in the control group. 
At the same time, 21 (17.5%) patients of the main group underwent 
ELPCHT  and RLPT in combination with hypoxiradiotherapy (HRT); in the 
control group, this type of treatment was used in 19 (15.8%) patients. Other 23 
(19.2%) patients of the main group and 24 (20.0%) patients of the control group 
received only ELPCH and RLPCH. 
Thin polyethylene catheters (PE10) were used for cannulation of the 
lymphatic vessels (Fig. 1). 
 
 
Fig. 1 Methods of catheterization of the peripheral lymphatic vessel of 
the lower limb. 1 - mandrin of an epidural catheter; 2 - polyethylene catheter 
PE 10; 3 - clamp. 
 
Direct introduction of the cytostatic agent into the lymphatic channel 
provides a direct supply of the drug to the tumor and to metastases in the regional 
lymph nodes. This leads to an increase in the antitumor effect of chemotherapy 
with a decrease in the general and local toxicity of chemotherapy. 
The duration of ELCHT was 96 hours continuously: 
1) methotrexate (Mtx) - 50 mg / m2 for 24 hours in 24 hours, 1 day; 
2) 5-fluorouracil (5-Fu) - 1000 mg / m2 for 24 hours, 2, 3 days - 48 hours. 
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RLPCH (with the preliminary introduction of a cocktail of 
lymphostimulants, consisting of: Novocain - 0.25% - 4 ml, heparin - 2500 U, 
furosemide - 0.5 ml): 
1) Mtx - 50 mg / m2 1 time, 4 days; 
2) 5-Fu - 1000 mg / m2 1 time, 5.6 days. 
The catheter is cut 2-3 mm longer than the mandrel. The protruding end of 
the catheter is fixed with a clamp and stretched until the catheter becomes thin 
(0.25-0.45 mm), while it should fit snugly against the mandrel. Then the catheter is 
cut 1-2 mm shorter than the mandrel. 
Lymphatic catheterization for long-term administration of drugs was carried 
out as follows. The site of the procedure was chosen large interdigital gap on the 
rear foot. After treating the skin with 5% iodine solution and 96% alcohol, 1 ml of 
1% methylene blue or 0.4% indigo carmine diluted in 0.25% 1.0 ml novocaine 
solution is introduced into the first interdigital space to stain the lymphatic vessel; 
retreating 5-6 cm upwards, a longitudinal skin incision of 2-3 cm was performed, a 
stained lymphatic vessel was found, it was isolated from adipose tissue and a 
dental spatula was placed under it. Previously, two ligatures were performed under 
the vessel, which were fixed with clamps directed to the proximal part of the 
wound. 
To enlarge the vessel in diameter, it was pinched, pressing it above the 
incision with fingers. A cotton swab produced massage below the incision. After 
filling the vessel and increasing its size in diameter, a dental spatula was brought to 
the distal part of the wound. The lymphatic vessel became inactive. The vessel was 
punctured in its lower part by a specially prepared catheter, which was fixed with 
ligatures in two places above the entry into the lymphatic vessel. Then the 
mandrinwas removed, the lymphatic vessel was checked for leaks by introducing a 
solution of novocaine through a catheter. 2-3 nodal sutures were applied to the 
skin. The free edge of the catheter was fixed with a band-aid to the skin. A needle 
was inserted into the free end and a chemotherapeutic system was connected. The 
drugs were injected with an electronic dispenser (ДЛВ-1) at a rate of 1.0 ml / h. 
within 72 hours. In this case, Mtx was administered continuously - 50 mg / day x 
m2 for 24 hours, on days 2 and 3 of 5-Fu - 1000 mg / day x m2 for 48 hours. Then 
the lymphatic catheter was removed, and after treating the wound with 5% iodine, 
an aseptic dressing was applied. 
After 6 days, a peripheral lymphatic vessel was catheterized on the back of 
the other foot, and the remaining half of the course dose of chemotherapy was 
slowly introduced into the catheter. 
On the 4th day, RLPСHT was performed by injecting drugs into pararectal 
fiber, taking into account the localization of the tumor (Fig. 2). 
 
11
Yusupbekov et al.: OPPORTUNITIES FOR ORGAN-SAVING SURGERIES IN THE COMPLEX TREATMENT
Published by 2030 Uzbekistan Research Online, 2019
Central Asian Journal of Medicine 
uzjournals.edu.uz/tma 183 2020#1 
 
Fig. 2. Conducting regional lymphatic chemotherapy for colorectal cancer. 
 
So, in case of a lesion of the anal canal by a tumor, the preparations were 
injected into the perianal tissue, and in case of the tumor of the middle and upper 
ampullar parts of the rectum, it was injected into the pararectal tissue closer to the 
tumor (i.e., to a depth of 8-10 cm from the skin). 
To perform RLPCHT after thoroughly treating the perianal skin with 5% 
iodine solution and 76% alcohol, departing from the transition line 2 cm laterally, 
under the control of the finger inserted into the rectum, a needle was inserted into 
the pararectal tissue, leading its end towards the tumor. 
For lymphostimulation, a cocktail of 0.25% 4.0 ml novocaine solution, 0.5 
ml furosemide solution and 2500 IU heparin solution was administered. Then, 
without removing the needle, 3-5 minutes after complete lymphostimulation, the 
chemotherapy was administered through the same needle. Having removed the 
needle, a warming 40% alcohol compress was applied to this area for 5-6 hours. 
RLPCHT was performed on days 4 and 5, on day 4,Mtx was administered - 50 mg, 
then on day 5 5-Fu - 1000 mg of chemotherapy. 
Along with the lymphotropic administration of water-soluble chemotherapy 
drugs, detralex was used 2 tablets 3 times a day during the course of chemotherapy 
in order to stimulate lymph drainage and lymphosorption in the lower extremities, 
to improve the penetration of chemotherapy drugs into the peripheral lymphatic 
channel and increase the concentration of these drugs in the lymph. 
To prevent thrombosis in the lymphatic and venous bloodstream, a low 
molecular weight anticoagulant, fraxiparine, was administered at a dose of 0.3 ml 
subcutaneously 1 time per day during the administration of chemotherapy, under 
the control of PTI and VSK. In order to reduce the local cytotoxic effect by 
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additional dilution of the residual amount of chemotherapy drugs in the tissues and 
at the same time to re-stimulate their lymphosorption, a 0.5% novocaine solution 
up to 50 ml was injected subcutaneously at the site of the previous chemotherapy 
injection, immediately after removing the cuff from the hip. At the end of the 
procedure for the lymphotropic administration of water-soluble chemotherapy 
drugs to improve venous outflow and prevent venous thrombosis of the lower 
extremities, elastic bandaging of the lower extremities was performed after 
subcutaneous administration of novocaine. 
Surgery was performed 7-14 days after the last lymphatic administration of 
drugs, during the period of the most pronounced decrease in the biological activity 
of the tumor due to PCHT. 
 Results and discussion. The results of organ-preserving operations in the 
complex treatment of CRC were observed during three and five years. Cases of 
relapses and metastases were analyzed, and the survival of patients over a three- 
and five-year period was evaluated, depending on prognostic factors. 
During the three-year observation, local relapses in the main group occurred 
in 10 (16.6%) patients with RC and in the control group in 13 (21.7%) patients. 
Relapses developed at follow-up from 6 to 27 months. The average relapse rate 
was 11,82,4 months. 
 
Table 9 
The frequency of relapse over a three-year period in patients with colorectal 
cancer, depending on the type of surgical treatment 
Type of operation  
The number of patients in 
groups 
Patients groups 
Main, 
n=60 
Control, 
n=60 
Аbs. % Аbs. % 
PRR with the 
anastomosis 
main, n=12 1 8,3 – – 
PARR with the 
relegation  
proximal colon 
in the anal canal 
 
main, n=14 
 
 
2 
 
14,2 
– – 
PARR with the 
relegation 
sigma in anal canal 
main, n=25 
 
5 20,0 – – 
PARRwith colostomy main, n=6 
 
1 16,6 – – 
Hartmann's operation main, n=3 1 33,3 – – 
PPER with 
sigmostomy 
control, n=60 – – 13 21,7 
Total: 10 16,6 13 21,7 
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The results of a univariate analysis showed that the frequency of relapse 
over a three-year period in patients with RR was higher after the PPER in 13 
(21.7%) patients than in organ-preserving operations in 10 (16.6%) patients. 
The frequency of relapse over a three-year period in patients with colorectal 
cancer, depending on the type of preoperative lymphatic chemotherapy: 
An analysis of the dependence of the recurrence rate on the lymphatic 
chemotherapy regimen revealed that, in the ELPCHT + RLPCHT + HRT regimen, 
a smaller number of tumor relapses was observed compared to the regimen without 
HRT. In the main group of patients, in the first case, relapses were observed in 3 
(14.2%) patients, while in the case of PCHT without HRT, in 4 (17.3%) patients. 
The number of relapses in the case of a single GRT of 13 Gray turned out to 
be slightly lower compared with the ROD of 5 Gy to SOD 25 Gy. So, in the main 
group of patients with RC, with a 13 Gy GRT regimen, relapses were detected in 3 
(14.2%) patients, and with a 5 Gy ROD regimen up to 25 Gy SOD, in 3 (18.7%) 
patients. 
In stage IIa of the disease, the number of relapses was minimal and was 
observed in the main group in 1 (10.0%) patients with PKK, in stage IIb in 2 
(12.5%), and in stage IIIb, the maximum number of relapses was found in 7 ( 
20.6%) of patients. 
The histological structure of the tumor also influenced the development of 
relapses in the distant postoperative period. The maximum number of tumor 
relapses in patients of the main group was found in undifferentiated form of cancer 
in 1 (33.3%) patients, in moderately differentiated adenocarcinoma in 5 (20.0%), 
and in low-grade adenocarcinoma in 3 (20.0%) ) The least relapses were observed 
with highly differentiated adenocarcinoma - in 1 (7.1%) patients with CRC. 
The macroscopic form of tumor growth also significantly affected the 
number of recurrences of  RC. In the endophytic form of growth in the main group, 
we observed the highest number of relapses - in 4 (25.0%) patients, in the 
exophytic form - the smallest number of relapses - in 1 (7.1%), and in the mixed 
form of tumor growth, relapses were found in 5 (16.7%) patients. 
Over a three-year period, tumor metastases to distant organs (liver and 
lungs) occurred in the main group in 5 (8.3%) patients with RC and in the control 
group in 4 (6.7%) patients. Metastases developed in the period from 6 to 18 
months, which averaged 11,32,5months. 
Moreover, the type of surgical intervention significantly influenced the 
development of metastases in the distant postoperative period, which is associated 
with various morbidity and volume of resected tissues of various surgical 
techniques. So, after Hartmann’s operation, distant metastases occurred in 2 
(66.7%) patients, after PARR with the relegation of the colon into the anal canal - 
in 1 (7.1%), after  PPER with sigmostomy - in 4 ( 6.7%) and after PARR  with the 
relegation of tyesygma into the anal canal - in 2 (8.0%) patients. 
As a result of ELPCHT + RLPCHT in combination with HRT, distant 
metastases developed in 1 (4.8%) patients with major group RC, while metastases 
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were detected in 2 (8.7%) patients with the same chemotherapeutic effect, but 
without HRT . 
At the same time, significant differences in the incidence of metastases over 
a three-year period in patients with colorectal cancer depending on the type of 
preoperative radiation therapy were not observed. So, after a single GDT at a dose 
of 13 Gy in the main group, metastases developed in 1 (4.8%) patients, and after an 
irradiation regimen of ROD of 5 Gy to SOD of 25 Gy - in 1 (6.2%) patients. 
The incidence of metastases in the distant postoperative period also 
depended on the stage of the tumor process. So, in stage III b, metastases were 
detected in 4 (11.7%) patients of the main group, in stage II b - in 1 (6.2%) and 
metastases were not observed in stage II a. 
The histological structure of the tumor also influenced the development of 
distant metastases. In the main group of patients with cricoid-cell form of cancer, 
metastases were found in 1 (100%) patients, with low differentiated 
adenocarcinoma - in 1 (6.7%), and with moderately differentiated adenocarcinoma 
- in 3 (12.0%). With highly differentiated adenocarcinoma, metastases were not 
observed. 
In the endophytic form of tumor growth, metastases in the long-term 
postoperative period were determined in 2 (12.5%) patients of the main group, in 
the exophytic form of growth in 1 (7.1%), and in the mixed form of tumor growth 
in 3 (10.0 %) patients with RC. 
An analysis of the three-year observation of patients with RC, depending on 
the type of surgical treatment performed, showed that the highest rate was 
observed after RC with anastomosis, where it was 91.7%. 3-year observation of 
patients after PARR with relegation of the colon was 85.7%, after PARR with 
relegation of sigma into the anal canal - 84.0%, after PPER with sigmostomy - 
81.6%, after PARR with colostomy - 83.3%, and after Hartmann's operation - 
66.7%. 
The study of the three-year observation of patients with RC depending on 
the type of preoperative lymphatic chemotherapy showed that after the treatment 
regimen ELPCHT + RLPCHT + HRT, this indicator in the main group was 86.4%, 
and after ELPCHT + RLPCHT without HRT - 83.7%. 
At the same time, the three-year observation rates after preoperative 
radiation therapy were almost identical and amounted to 83.8% after a single HRT 
at a dose of 13 Gy in the main group, and 80.6% after an ROD of 5 Gy to an SOD 
of 25 Gy. 
The stage of the disease significantly affected the indicators of three-year 
observation of patients with RC. So, in the main group of patients, this indicator in 
stage IIa was 90.0%, in stage IIb - 87.5%, in stage IIIb - 79.4%. 
The histological form of the tumor also significantly affected the three-year 
observation of patients with RC. In the main group of patients with cricoid 
adenocarcinoma and with undifferentiated cancer, mortality of patients for this 
period of time was not observed. With highly differentiated adenocarcinoma, this 
indicator was 92.8%, with moderately differentiated adenocarcinoma - 88.0%, with 
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low-grade adenocarcinoma - 80.0%. Three-year survival rates for low-grade cancer 
were 33.3%. 
Three-year observation with the exophytic form of tumor growth in the main 
group of patients with RC was 92.8%, with the endophytic form - 75.0% and with 
the mixed form of tumor growth - 83.3%. 
An analysis of the five-year survival of patients with PKK, depending on the 
type of surgical treatment performed, showed that the highest rate was observed 
after PRR with anastomosis, where it was 83.3%. the five-year survival rate of 
patients after PARR  with relegation  of the  colon was 71.4%, after PPER  with 
sigmostomy - 81.6%, after PARR  with sigma relegation  in the anal canal - 68.0%, 
after PARR with colostomy - 50.0%, and after Hartmann's operation - 66.7%. 
A study of the five-year survival of patients with RC depending on the type 
of preoperative lymphatic chemotherapy showed that after the treatment regimen 
ELPCHT + RLPCHT + HRT, this indicator in the main group was 76.1%, and 
after ELPCHT + RLPCHT without HRT - 69.6%. 
At the same time, the five-year observation rates in the main group of 
patients after preoperative radiation therapy were slightly lower and made to 
76.2% after a single HDT at a dose of 13 Gy in the main group, and 62.5% after 
the radiation treatment regimen of 5 Gy to SOD 25 Gy. 
The stage of the disease significantly affected the five-year observation of 
patients with RC. So, in the main group of patients, this indicator in stage IIa was 
80.0%, in stage IIb - 81.2%, in stage IIIb - 61.8%.  
In the main group of patients with undifferentiated cancer, with cricoid 
adenocarcinoma, with mucous cancer, with squamous cancer, five-year 
observation was not carried out. With highly differentiated adenocarcinoma, this 
indicator was 78.6%, - 80.0%, with moderately differentiated adenocarcinoma - 
88.0%, with low-grade adenocarcinoma - 60.0%. 
Five-year observation with an exophytic form of tumor growth in the main 
group of patients with RC was 78.6%, with an endophytic form - 56.2% and with a 
mixed form of tumor growth - 73.3%. 
CONCLUSIONS 
1. An analysis of postoperative complications of a general nature showed 
that their number did not depend on the type of surgical intervention. The rather 
large clinical material shows the possibility of performing organ-preserving 
operations in patients with lower ampullar cancer of the rectum. 
2. A new method has been developed for the complex treatment of patients 
with colorectal cancer, including preoperative high-dose hypoxiradiotherapy 
according to schemes with a single exposure at a dose of 13 Gy (in 37 patients) and 
irradiation with medium fractions of 5 Gy up to SOD 25 Gy (in 36 patients), 
followed by organ-conserving operations. The five-year survival rate for patients 
with colorectal cancer after endolymphatic polychemotherapy and regional 
lymphatic chemotherapy with subsequent organ-preserving surgeries was 69.6%, 
with the addition of preoperative hypoxiradiotherapy to 76.1%. The five-year 
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survival rate after a single hypoxiradiotherapy at a dose of 13 Gy with subsequent 
organ-preserving surgeries was 76.1%, and after an irradiation regimen of ROD of 
5 Gy to SOD of 25 Gy - 62.5%. 
3. A new approach has been developed for the complex treatment of patients 
with colorectal cancer, including preoperative endolymphatic polychemotherapy 
and regional lymphatic polychemotherapy (in 47 patients), as well as in 
combination with hypoxiradiotherapy (in 40 patients), followed by organ-
preserving operations. 
4. An analysis of the five-year observation of patients with RC, depending 
on the type of surgical treatment, showed that the highest rate was observed after 
PRR with anastomosis, where it was 83.3%. the five-year observation rate of 
patients after PARR with relegation of the colon was 71.4%, after PPER with 
sigmostomy - 81.6%, after PARR with sigma relegation in the anal canal - 68.0%, 
after PARR with colostomy - 50.0%, and after Hartmann's operation - 66.7%. In 
patients of the control group, the five-year observation rate after performing  PPER 
with sigmostomy was 68.3%. 
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